Graeme J. Moyle

Corporate Officer/Principal bij Chelsea & Westminster Hospital

60 jaar

Health Technology

Consumer Services

Actieve functies van Graeme J. Moyle

Bedrijven	Functie	Begin	Einde
Chelsea & Westminster Hospital	Corporate Officer/Principal	01-01-1994	-

Bedrijven	Functie	Begin	Einde
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Directeur/Bestuurslid	23-06-2014	-
	Independent Dir/Board Member	23-06-2014	-

University of Adelaide

Doctorate Degree

Internationaal

Operationeel

Director/Board Member	1
Independent Dir/Board Member	1
Doctorate Degree	1

Sectoraal

Health Technology	2
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	2
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Health Technology
Chelsea & Westminster Hospital

Bedrijven in privébezit

Health Technology

Chelsea & Westminster Hospital